Results 211 to 220 of about 47,644 (242)
Some of the next articles are maybe not open access.

Aromatase inhibitors in pediatrics

Nature Reviews Endocrinology, 2011
Aromatase, an enzyme located in the endoplasmic reticulum of estrogen-producing cells, catalyzes the rate-limiting step in the conversion of androgens to estrogens in many tissues. The clinical features of patients with defects in CYP19A1, the gene encoding aromatase, have revealed a major role for this enzyme in epiphyseal plate closure, which has ...
Wit, J.M., Hero, M., Nunez, S.B.
openaire   +3 more sources

Aromatase inhibition by flavonoids

The Journal of Steroid Biochemistry and Molecular Biology, 1990
Several synthetic flavones were found to inhibit the aromatization of androstenedione to estrone catalyzed by human placental microsomes. Twenty-one compounds were tested and the IC50 of the most active were: flavone, 10 microM; 7-hydroxyflavone, 0.5 microM; 7,4'-dihydroxyflavone, 2.0 microM; flavanone, 8.0 microM; and 4'-hydroxyflavanone, 10 microM ...
A R, Ibrahim, Y J, Abul-Hajj
openaire   +2 more sources

Aromatase in Aging Women

Seminars in Reproductive Medicine, 1999
Cessation of ovarian estrogen secretion is the key event during the climacteric. An enzyme termed aromatase in a number of human tissues and cells, including ovarian granulosa cells, the placental syncytiotrophoblast, adipose and skin fibroblasts, bone, and the brain, catalyzes the conversion of C19 steroids to estrogens.
S E, Bulun   +3 more
openaire   +2 more sources

Human Aromatase

Drug Metabolism Reviews, 1989
S A, Chen   +4 more
openaire   +2 more sources

Aromatase inhibitors and teratogenesis

Fertility and Sterility, 2004
letter to the ...
openaire   +2 more sources

Aromatase Deficiency and Aromatase Excess

2014
Jonathan F. Russell   +2 more
openaire   +1 more source

Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer

Circulation, 2020
Laurent Azoulay   +2 more
exaly  

Home - About - Disclaimer - Privacy